Evolent Health, Inc. (EVH) Earnings History
Net Loss14 years of earnings data (2012–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Evolent Health, Inc. (EVH) Earnings Overview
As of June 22, 2026, Evolent Health, Inc. (EVH) reported trailing twelve-month net income of -$497M, reflecting -525.9% year-over-year growth. The company earned $-4.44 per diluted share over the past four quarters, with a net profit margin of -28.5%.
Looking at the long-term picture, EVH's historical earnings data spans multiple years. The company achieved its highest annual net income of $332M in fiscal 2015.
Evolent Health, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PINC (-$24M net income, 2.0% margin), ALHC ($20M net income, -0.0% margin), HQY ($231M net income, 16.4% margin), EVH has room to improve margins relative to the peer group. Compare EVH vs PINC →
EVH Earnings vs Peers
Earnings metrics vs comparable public companies
EVH Historical Earnings Data (2012–2025)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$535M | -767.4% | -$4M | $-5.07 | -28.5% | -0.2% |
| 2024 | -$62M | +45.5% | -$40M | $-0.81 | -2.4% | -1.6% |
| 2023 | -$113M | -489.9% | -$71M | $-1.28 | -5.8% | -3.6% |
| 2022 | -$19M | +49.0% | $4M | $-0.20 | -1.4% | 0.3% |
| 2021 | -$38M | +88.8% | -$42M | $-0.36 | -4.1% | -4.7% |
| 2020 | -$334M | -10.7% | -$263M | $-3.94 | -36.1% | -28.4% |
| 2019 | -$302M | -473.5% | -$309M | $-3.71 | -43.9% | -45.0% |
| 2018 | -$53M | +13.2% | -$47M | $-0.68 | -8.4% | -7.6% |
| 2017 | -$61M | +62.0% | -$73M | $-0.94 | -13.9% | -16.7% |
| 2016 | -$160M | -148.0% | -$237M | $-3.55 | -62.8% | -93.4% |
| 2015 | $332M | +1417.0% | -$43M | $7.21 | 343.2% | -44.4% |
| 2014 | -$25M | -226.1% | -$25M | $-0.66 | - | - |
| 2013 | $20M | +203.9% | -$21M | $0.06 | 78.0% | -82.4% |
| 2012 | -$19M | - | -$20M | $-0.50 | -230.8% | -235.1% |
Download Data
Export EVH earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
14+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
EVH — Frequently Asked Questions
Quick answers to the most common questions about buying EVH stock.
What is EVH earnings per share (EPS)?
EVH trailing twelve-month (TTM) diluted EPS is $-4.44, reflecting -525.9% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2012 to 2025 is available in the table on this page.
What is Evolent Health, Inc.'s net income?
Evolent Health, Inc. (EVH) trailing twelve-month net income is $-497M as of 2025. Earnings declined -525.9% year-over-year.
Is EVH profitable?
EVH is not currently profitable on a TTM basis, reporting a net loss of $-497M. Net margin is -28.5%. Investors should monitor for a return to profitability.
What is EVH's earnings growth rate?
EVH compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2012 to 2025.
What are EVH's profit margins?
Evolent Health, Inc. net profit margin is -28.5%, operating margin is -0.2%, and gross margin is +15.1%. Below-average margins reflect competitive or cost pressures. Return on Equity is -75.5%.
Is EVH growing earnings?
EVH earnings are declining — EPS fell -525.9% year-over-year. TTM net income dropped to $-497M. This contrasts with the 5-year CAGR of N/A.
What was EVH's best earnings year?
Evolent Health, Inc.'s highest annual net income on record is $332M, achieved in fiscal year 2015. Earnings history on this page spans 2012 to 2025 and includes all annual and quarterly figures.
What were EVH's earnings last quarter?
EVH's most recent reported quarter was Q1 2026. Net income was $-27M with diluted EPS of $-0.24. For a full breakdown of all quarters, see the quarterly earnings table on this page.